Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development		$ 3,871	$ 5,837	$ 11,498	$ 10,177
General and administrative		4,095	3,745	7,404	7,379
Loss from operations		(7,966)	(9,582)	(18,902)	(17,556)
Other income (expense), net:
Interest expense		(46)	(372)	(207)	(740)
Interest income and other income (expense), net		142	384	379	822
Total other income (expense), net		96	12	172	82
Provision for income taxes		0	0	0	0
Net loss		$ (7,870)	$ (9,570)	$ (18,730)	$ (17,474)
Net loss per share of common stock, RSUs and pre-funded warrants, basic	[1]	$ (2.07)	$ (5.52)	$ (5.17)	$ (10.15)
Net loss per share of common stock, RSUs and pre-funded warrants, diluted	[1]	$ (2.07)	$ (5.52)	$ (5.17)	$ (10.15)
Weighted-average shares of common stock, RSUs and pre-funded warrants outstanding, basic	[1]	3,802,956	1,734,335	3,621,329	1,722,327
Weighted-average shares of common stock, RSUs and pre-funded warrants outstanding, diluted	[1]	3,802,956	1,734,335	3,621,329	1,722,327

[1] Results, including shares of common stock, have been adjusted to reflect the one-for-thirteen stock split effected in April 2025. See Note 1, Organization and Description of the Business, for details.